Results 191 to 200 of about 92,477 (262)

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate

Histopathology, Volume 89, Issue 2, Page 240-250, August 2026.
FOXA1 is a highly sensitive diagnostic marker for prostate cancer. Besides prostatic adenocarcinoma, it is also expressed in 57%–80% of metastatic or primary prostatic small cell carcinomas, which lose traditional prostatic markers including NKX3.1. Although it is less specific than NKX3.1, it can serve as a valuable adjunct for confirming prostatic ...
Jianping Zhao, Jun Yao, Hossein Hosseini, Ezra Baraban, Ruihe Lin, Charles C. Guo, Lei Huo, Wei Lu, Khaja Khan, Shufang Wang, Luisa Maren Solis Soto, Qingqing Ding   +11 more
wiley   +1 more source

Retraction: GNA14 silencing suppresses the proliferation of endometrial carcinoma cells through inducing apoptosis and G2/M cell cycle arrest. [PDF]

Biosci Rep
Hang B, Wang J, Lv X, Xu F, Wei M, Liu C, Yang Y.   +6 more
europepmc   +1 more source

Life Course Trajectories of Body Mass Index and Risk of Cancer in Adulthood: Systematic Review and Meta‐Analysis

Obesity Reviews, Volume 27, Issue 8, August 2026.
ABSTRACT Objective This systematic review and meta‐analysis aimed to identify common life‐course body mass index (BMI) trajectories (childhood/adulthood to adulthood) and their impact on risk of cancer overall and cancer at different sites in adulthood. Methods Observational studies were identified that assessed the association of BMI trajectories with
Samira Behboudi‐Gandevani, Tommy Haugan, Nayla Cristina Do Vale Moreira, Ellen Christin Arntzen, Moira Strand Hutchinson, Melanie Nichols, Razieh Bidhendi‐Yarandi   +6 more
wiley   +1 more source

Evaluation of Real-Life Data on Toxicity in Elderly Patients Undergoing Adjuvant External Beam Radiotherapy for Endometrial Carcinoma. [PDF]

Cancers (Basel)
Zarour K, Hermann RM, Nitsche M, Carl CO, Bruns F, Cieslak A, Meinecke D, Sonnhoff MA.   +7 more
europepmc   +1 more source

Adjuvant radiotherapy for FIGO 2023 stage IC endometrial carcinoma. [PDF]

Turk J Obstet Gynecol
Kahvecioğlu A, Yüce Sarı S, Gültekin M, Yiğit E, Arık Z, Usubütün A, Akgör U, Başaran D, Özgül N, Yıldız F.   +9 more
europepmc   +1 more source

Recurrent endometrial carcinoma with immune-mediated thrombocytopenia following durvalumab: A case report. [PDF]

Case Rep Womens Health
Sakakibara A, Nagai S, Shirane T, Sakai T, Fujioka Y, Hino M, Hattori Y, Kurahashi T.   +7 more
europepmc   +1 more source

Predictive Biomarkers for Immunotherapy in Endometrial Carcinoma. [PDF]

Cancers (Basel)
Pizzimenti C, Fiorentino V, Pepe L, Franchina M, Ruggeri C, Ercoli A, Ciappina G, Berretta M, Tuccari G, Ieni A.   +9 more
europepmc   +1 more source

Characterization of T cell markers in endometrial carcinoma through single-cell RNA sequencing. [PDF]

Discov Oncol
Zhao M, Zhou L.
europepmc   +1 more source

Implementation of Robotic-Assisted Surgery for the Treatment of Patients with Endometrial Carcinoma. [PDF]

Cancers (Basel)
Shaalan W, Haßdenteufel K, Hoppe F, Sinn P, Togawa R, Tretschock LM, Batarseh D, Ylitalo H, Hassan N, Schäfgen B, Hennigs A, Smetanay K, Schneeweiss A, Nees LK, Riedel F, Zivanovic O.   +15 more
europepmc   +1 more source